The RING finger protein family in health and disease

C Cai, YD Tang, J Zhai, C Zheng - Signal transduction and targeted …, 2022 - nature.com
Ubiquitination is a highly conserved and fundamental posttranslational modification (PTM) in
all eukaryotes regulating thousands of proteins. The RING (really interesting new gene) …

Engaging chromatin: PRC2 structure meets function

P Chammas, I Mocavini, L Di Croce - British journal of cancer, 2020 - nature.com
Abstract Polycomb repressive complex 2 (PRC2) is a key epigenetic multiprotein complex
involved in the regulation of gene expression in metazoans. PRC2 is formed by a tetrameric …

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i (17)(q10) …

M Meggendorfer, U Bacher, T Alpermann, C Haferlach… - Leukemia, 2013 - nature.com
Chronic myeloid malignancies are categorized to the three main categories
myeloproliferative neoplasms (MPNs), myelodysplastic syndromes (MDSs) and MDS/MPN …

CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms

SC Meyer, MD Keller, S Chiu, P Koppikar… - Cancer cell, 2015 - cell.com
Although clinically tested JAK inhibitors reduce splenomegaly and systemic symptoms,
molecular responses are not observed in most myeloproliferative neoplasm (MPN) patients …

[HTML][HTML] Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms

J Grinfeld, J Nangalia, AR Green - Haematologica, 2017 - ncbi.nlm.nih.gov
The myeloproliferative neoplasms are a heterogeneous group of clonal disorders
characterized by the overproduction of mature cells in the peripheral blood, together with an …

Molecular targeted therapy and immunotherapy for myelodysplastic syndrome

P Lee, R Yim, Y Yung, HT Chu, PK Yip… - International Journal of …, 2021 - mdpi.com
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder
characterized by ineffective hematopoiesis, cytopenia, morphologic dysplasia, and …

The myelodysplastic syndrome as a prototypical epigenetic disease

JPJ Issa - Blood, The Journal of the American Society of …, 2013 - ashpublications.org
The myelodysplastic syndrome (MDS) is a clonal disorder characterized by increased stem
cell proliferation coupled with aberrant differentiation resulting in a high rate of apoptosis …

Molecular diagnostics of myeloproliferative neoplasms

SE Langabeer, H Andrikovics, J Asp… - European Journal of …, 2015 - Wiley Online Library
Since the discovery of the JAK 2 V617F mutation in the majority of the myeloproliferative
neoplasms (MPN) of polycythemia vera, essential thrombocythemia and primary …

Turning the tide in myelodysplastic/myeloproliferative neoplasms

MWN Deininger, JW Tyner, E Solary - Nature Reviews Cancer, 2017 - nature.com
Myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) are aggressive
myeloid malignancies recognized as a distinct category owing to their unique combination of …

Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia

L Palomo, M Ibanez, M Abáigar… - British Journal of …, 2020 - Wiley Online Library
The landscape of medical sequencing has rapidly changed with the evolution of next
generation sequencing (NGS). These technologies have contributed to the molecular …